ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,614Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1171

$714K Total Retail Price of All Prescriptions

Rank: 94 out of 1171

635 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 635 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 12,570 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 711 659 1 1
AMLODIPINE BESYLATE 587 568 2 2
LEVOTHYROXINE SODIUM 477 459 3 4
LISINOPRIL 369 337 4 3
OMEPRAZOLE 322 290 5 5
FUROSEMIDE 287 257 6 6
PRAVASTATIN SODIUM 281 265 7 13
ATORVASTATIN CALCIUM 275 255 8 10
LOSARTAN POTASSIUM 270 264 9 14
METOPROLOL SUCCINATE 256 232 10 17
METFORMIN HCL 224 185 11 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 215 198 12 26
SERTRALINE HCL 209 186 13 23
NAMENDA 200 200 14 42
TRIAMTERENE-HCTZ 199 172 15 58
HYDROCODONE-ACETAMINOPHEN 197 179 S3 16 8
CARVEDILOL 197 190 16 20
METOPROLOL TARTRATE 195 188 18 11
CITALOPRAM HBR 184 170 19 22
DONEPEZIL HCL 184 178 19 24
LOSARTAN-HYDROCHLOROTHIAZIDE 176 171 21 40
LOVASTATIN 167 167 22 36
ATENOLOL 158 146 23 15
MIRTAZAPINE 154 154 24 50
ALENDRONATE SODIUM 147 141 25 33
CHLORTHALIDONE 144 136 26 116
METFORMIN HCL ER 143 138 27 52
FLUTICASONE PROPIONATE 140 122 28 30
HYDROCHLOROTHIAZIDE 131 129 29 9
WARFARIN SODIUM 126 113 30 12
SPIRONOLACTONE 126 108 30 53
TRAMADOL HCL 108 101 32 18
TRAZODONE HCL 107 85 33 37
GABAPENTIN 106 104 34 16
CLOPIDOGREL 102 101 35 35
ALLOPURINOL 99 95 36 31
FELODIPINE ER 98 98 37 165
GLIMEPIRIDE 94 94 38 34
CRESTOR 85 78 39 27
VENLAFAXINE HCL ER 82 79 40 113
FINASTERIDE 82 82 40 88
GLIPIZIDE ER 80 52 42 86
LANTUS 80 73 42 46
PREDNISONE 79 76 44 39
LEVETIRACETAM 78 66 45 84
ZOLPIDEM TARTRATE 77 68 46 21
NEXIUM 71 57 47 25
PLAVIX 68 67 48 55
SPIRIVA 67 61 49 57
ADVAIR DISKUS 66 55 50 51
BUMETANIDE 65 57 51 93
AMITRIPTYLINE HCL 65 57 R 51 74
CYMBALTA 65 56 51 64
PANTOPRAZOLE SODIUM 64 64 54 29
FAMOTIDINE 62 57 55 75
CLONIDINE HCL 61 48 56 45
HYDRALAZINE HCL 60 58 57 60
AMLODIPINE BESYLATE-BENAZEPRIL 60 56 57 70
POTASSIUM CHLORIDE 59 47 59 19
POLYETHYLENE GLYCOL 3350 59 45 59 72
TERAZOSIN HCL 58 57 61 143
DIOVAN 56 48 62 32
QUETIAPINE FUMARATE 54 54 63 54
TAMSULOSIN HCL 54 50 63 28
LANTUS SOLOSTAR 53 40 65 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.